Seqens Seqens

X
[{"orgOrder":0,"company":"Meridian Medical Technologies","sponsor":"ASPR","pharmaFlowCategory":"D","amount":"$9.9 million","upfrontCash":"Undisclosed","newsHeadline":"Meridian Medical Technologies, Kindeva Drug Delivery\u2019s Global Health Security Division, Awarded Contract to Supply DuoDote\u00ae","therapeuticArea":"Pharmacology\/Toxicology","highestDevelopmentStatus":"Approved","country":"U.S.A","productType":"Small molecule","productStatus":"Approved","date":"November 2023","url1":"","url2":"","graph1":"Pharmacology\/Toxicology","graph2":"Approved"}]

Find Clinical Drug Pipeline Developments & Deals for DSSTox_CID_3495

Menu
Loading...
Filters Filter
×
FILTER:
filter Company
    filter Sponsor
      filter Country
        filter Therapeutic Area
          filter Study Phase

            Active Filter(s):

            Companies By Therapeutic Area

            Development Status

            Details:

            Under the agreement, Meridian will supply DuoDote to the Administration for Strategic Preparedness and Response within the United States. DuoDote® is an FDA-approved dual-chamber autoinjector (atropine and pralidoxime chloride) chemical nerve agent antidote.

            Lead Product(s): Atropine,Pralidoxime Chloride

            Therapeutic Area: Pharmacology/Toxicology Product Name: DuoDote

            Highest Development Status: Approved Product Type: Small molecule

            Partner/Sponsor/Collaborator: ASPR

            Deal Size: $9.9 million Upfront Cash: Undisclosed

            Deal Type: Agreement November 14, 2023

            ASK
            US
            PHARMACOMPASS
            Upload
            your Pipeline Activity
            Post Enquiry
            POST ENQUIRY